G. Sperling 2012 Irrevocable Trust No. 3 John is 10% at Arcadia Biosciences, Inc. (RKDA). They have made 1 open-market trade across 1 company since 2015, most recently 2015-05-20.
CIK 0001641772
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $8.0M since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RKDA | 1,160,714 | $186K |
Shares reported on the most recent Form 4, priced at the 2015-05-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RKDA | BUY | 2015-05-20 | 2015-05-21 | $8.00 | $8.0M | -32.9% | -12.9% | -12.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.